March 08, 2026 14:00 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE)…
Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting…
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET | Source: Kamada Ltd. REHOVOT, Israel, and…
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…
Strong share gains and solid growth; operating leverage and cashflow drive deleveragingZURICH, Feb. 25, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT…
February 24, 2026 16:30 ET | Source: Cardiff Oncology, Inc. Reported positive update from Phase 2 CRDF-004 trial in first-line…
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology February 17, 2026 08:00 ET | Source:…